{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T19:07:08Z","timestamp":1767035228705,"version":"3.40.5"},"reference-count":8,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jns-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.jns.2017.01.068","type":"journal-article","created":{"date-parts":[[2017,1,26]],"date-time":"2017-01-26T03:45:19Z","timestamp":1485402319000},"page":"167-169","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Alglucosidase alfa therapy for Pompe disease in pregnancy \u2013 Case report"],"prefix":"10.1016","volume":"375","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1694-4925","authenticated-orcid":false,"given":"Justyna","family":"K\u0142os","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdalena","family":"Kwa\u015bniak-Butowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaros\u0142aw","family":"S\u0142awek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2017.01.068_bb0005","first-page":"82","article-title":"Pompe disease (glycogen storage disease type II): clinical features and enzyme replacement therapy","volume":"106","author":"van der Beek","year":"2006","journal-title":"Acta Neurol. Belg."},{"key":"10.1016\/j.jns.2017.01.068_bb0010","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMoa0909859","article-title":"A randomized study of alglucosidase alfa in late-onset Pompe's disease","volume":"362","author":"van der Ploeg","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jns.2017.01.068_bb0015","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ymgme.2012.09.015","article-title":"Open-label extension study following the Late-Onset Treatment Study (LOTS) of alglucosidase alfa","volume":"107","author":"van der Ploeg","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.jns.2017.01.068_bb0020","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.ymgme.2011.09.012","article-title":"First experience with enzyme replacement therapy during pregnancy and lactation in Pompe disease","volume":"104","author":"de Vries","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.jns.2017.01.068_bb0025","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1016\/S0149-2918(10)00079-2","article-title":"Pregnancy outcome in a Pompe disease patient treated with enzyme replacement therapy","volume":"32","author":"Lindberg","year":"2010","journal-title":"Clin. Ther."},{"key":"10.1016\/j.jns.2017.01.068_bb0030","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.nmd.2012.11.006","article-title":"Pregnancy during enzyme replacement therapy for late-onset acid maltase deficiency","volume":"23","author":"Zagnoli","year":"2013","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.jns.2017.01.068_bb0035","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1016\/j.ymgme.2013.12.131","article-title":"Outcome of pregnancy in Pompe disease with and without enzyme replacement therapy","volume":"111","author":"Kasturi","year":"2014","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.jns.2017.01.068_bb0040","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ymgme.2014.03.010","article-title":"Pregnancy and delivery in women with Pompe disease","volume":"112","author":"Karabul","year":"2014","journal-title":"Mol. Genet. Metab."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X1730076X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X1730076X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,7,3]],"date-time":"2018-07-03T06:47:10Z","timestamp":1530600430000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X1730076X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":8,"alternative-id":["S0022510X1730076X"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2017.01.068","relation":{},"ISSN":["0022-510X"],"issn-type":[{"type":"print","value":"0022-510X"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alglucosidase alfa therapy for Pompe disease in pregnancy \u2013 Case report","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2017.01.068","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}